Domain-specific Aerobic Exercise Training in Coronary Artery Disease
DOSE-EX-CAD
1 other identifier
interventional
105
1 country
1
Brief Summary
Exercise training in cardiac rehabilitation (rehab) is a key part of managing a patient with heart disease. It has been shown that cardiac patients who increase their aerobic ("cardio") fitness by exercise training live longer, have better quality of life, and stay out of hospitals more than patients who do not improve their aerobic fitness. The more a patient improves their aerobic fitness the greater the benefit. But it has been shown that more than half of patients do not improve their aerobic fitness even after participating in cardiac rehab. This may be related to how hard patients are asked to train (their training "intensity"). The way intensity is chosen in current programs is commonly based on a "one-size fits all" method that may not consider that different patients have different abilities. There are more personalized methods to determine training intensity that exist, but these have never been used in cardiac rehab. One method divides intensity into three zones (zone 1 = moderate intensity; zone 2 = heavy intensity; zone 3 = very high intensity) that are based on when an individuals' biological responses to exercise change. The purpose of this study is to see if this approach gives better results in terms of changes in aerobic fitness and if training in the different zones makes a difference. Three groups of patients will be asked to train for 3 months in one of the three intensity zones. Aerobic fitness before and after exercise training will be compared to see which intensity zone results in the largest change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
April 11, 2025
April 1, 2025
1.7 years
November 8, 2023
April 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Peak oxygen uptake
Post-training peak oxygen uptake achieved during a symptom-limited incremental exercise test to task failure
baseline (week 0) and week 14
Secondary Outcomes (3)
Positive responders
week 14
Gas exchange threshold
baseline (week 0) and week 14
Respiratory compensation point
baseline (week 0) and week 14
Other Outcomes (6)
Cardiac output
baseline (week 0) and week 14
Stroke volume
baseline (week 0) and week 14
Arterio-venous oxygen difference
baseline (week 0) and week 14
- +3 more other outcomes
Study Arms (3)
Moderate-intensity continuous training
EXPERIMENTAL\~50 min of constant-power output cycling, 3 x per week at 85% of gas exchange threshold
Heavy-intensity continuous training
EXPERIMENTAL30 min of constant-power output cycling, 3 x per week at 70% of the difference between gas exchange threshold and respiratory compensation point
High (severe)-intensity interval training
EXPERIMENTALintervals; 4 x 4 min on - 3 min off at 115% of respiratory compensation point (work) and 50-70% gas exchange threshold (recovery)
Interventions
Aerobic exercise training on a cycle ergometer
Eligibility Criteria
You may qualify if:
- Patients with CAD who do not have any identified left ventricular dysfunction (i.e., left ventricular ejection fraction \[LVEF\] \<50%) and who: were discharged from the hospital following admission for acute coronary syndrome (i.e., ST-elevation or non ST-elevation myocardial infarction, addressed with PCI or CABG, as documented by their attending physician; referred to St. Joseph's CRSP Program; completed a CPET at the St. Joseph's CRSP Program (as routine screening for cardiac rehabilitation) and have been cleared to exercise in a structured format (i.e., do not exhibit any contraindications to maximal exercise); without: respiratory or musculoskeletal issues that would prohibit them from cycling exercise.
You may not qualify if:
- Those who have: diagnosed heart failure, severe aortic stenosis, congenital coronary abnormality, 2-3° atrioventricular block, major arrhythmias such as atrial fibrillation (including paroxysmal), or are scheduled to undergo PCI or CABG surgery within 2 months following hospital discharge; are using insulin for diabetes; diagnosed with respiratory disease; or musculoskeletal issues that prohibit cycling exercise; and/or are unable to provide informed consent..
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Western Ontario
London, Ontario, N6A3K7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 8, 2023
First Posted
November 22, 2023
Study Start
November 1, 2024
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share